EUVIMEDEUVIMED entdecken
Crossref

Intelligent delivery of autophagy-targeting chimeric peptides by engineered exosomes for the degradation of α-synuclein

Yuteng Zeng, Ziyan Lv, Jiayu Liang, Yetao Wu, Liang Han

Acta Biomaterialia · 2026-05 · 215 · 288-301

DOI: 10.1016/j.actbio.2026.04.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-05. Verfasst von Yuteng Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, College of Pharmaceutical Sciences, Soochow University, Suzho…. Hauptthemen laut MEDLINE: alpha-Synuclein, Exosomes, Autophagy, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Priority Academic Program Development of Jiangsu Higher Education Institutions, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted degradation of the aggregated α-synuclein holds tremendous potential for treating Parkinson's disease (PD). However, most of the developed aggregated α-synuclein-specific degraders, e.g., autophagy-targeting chimeric peptides, are limited by the blood-brain barrier (BBB), substantia nigra (SN) neuron targetability, and intracytoplasmic release. To overcome these obstacles, we constructed an engineered exosome (EXO) equipped with surficial glucose-regulated protein 94 (GRP94)-targeting peptide N, luminal α-synuclein-degrading peptide P1, and cathepsin-B-cleavable GFLG as the linker between the exosome skeleton protein and P1, termed NEXOGFLG-P1. We verified that the NEXOGFLG-P1 exosomes could cross the BBB and target diseased SN neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP)-induced PD model mice. Following fusion with endosomes, the exposed P1 was released into the cytoplasm by cytoplasmic cathepsin B-mediated GFLG cleavage to degrade α-synuclein. Collectively, the NEXOGFLG-P1 exosomes exhibit a significant degradation effect on α-synuclein aggregates, providing a proof-of-concept platform for treating PD. STATEMENT OF SIGNIFICANCE: Targeted degradation of α-synuclein aggregates holds tremendous potential for the etiological treatment of Parkinson's disease (PD). However, most of current α-synuclein-specific degraders are stuck with low blood-brain barrier permeability, poor targetability for diseased cells, and uncontrolled release. Notably, α-synuclein predominantly affects neurons in the substantia nigra (SN) region rather than the whole brain. To overcome these obstacles, we constructed an engineered exosome, termed NEXOGFLG-P1, to specially deliver and release autophagy-targeting chimeric peptide to degrade α-synuclein in the diseased SN neurons through the autophagy-lysosomal pathway. The engineered exosomes exhibit the great potential in targeting diseased SN neurons and degrading α-synuclein aggregates, providing a proof-of-concept therapeutic platform for treating PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinExosomesAutophagyPeptidesAnimalsMiceHumansBlood-Brain BarrierMice, Inbred C57BLSubstantia NigraParkinson DiseaseProteolysisMale

Stichwörter der Autor:innen

Engineered exosomesParkinson's diseaseProtein degradationα-synuclein aggregates

Substanzen

alpha-SynucleinPeptides

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China.
  • Jiangsu Key Laboratory of Drug Discovery and Translational Research for Brain Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China; Jiangsu Province Engineering Research Center…

Förderung

  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Zeng, Y., Lv, Z., Liang, J., Wu, Y., & Han, L. (2026). Intelligent delivery of autophagy-targeting chimeric peptides by engineered exosomes for the degradation of α-synuclein. Acta Biomaterialia, 215, 288-301. https://doi.org/10.1016/j.actbio.2026.04.003

Vancouver

Zeng Y, Lv Z, Liang J, Wu Y, Han L. Intelligent delivery of autophagy-targeting chimeric peptides by engineered exosomes for the degradation of α-synuclein. Acta Biomaterialia. 2026;215:288-301. doi:10.1016/j.actbio.2026.04.003

BibTeX
@article{Zeng2026,
  author = {Zeng, Yuteng and Lv, Ziyan and Liang, Jiayu and Wu, Yetao and Han, Liang},
  title = {Intelligent delivery of autophagy-targeting chimeric peptides by engineered exosomes for the degradation of α-synuclein},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {215},
  pages = {288--301},
  doi = {10.1016/j.actbio.2026.04.003}
}
Kostenlos starten →